MTOR and colorectal carcinoma: Therefore, we hypothesized that CD147-mediated activation of the PI3K/AKT/mTOR pathway may upregulate HIF-1α, which further enhances glycolysis and induces 5-FU resistance in 5-FU-resistant CRC.